Proteasome-targeting drugs tested on NF2-deficient meningioma models
syn65467792
Created By
Anh Nguyet Vu avu
title: Proteasome-targeting drugs tested on NF2-deficient meningioma models
funder: CTF
creator: Vijaya Ramesh
license: UNKNOWN
species: Homo sapiens Mus musculus
studyId: syn27761862
subject: Meningioma Neurofibromatosis 2 Drug screening Cell lines Antineoplastic agents Proteasome inhibitors
dataType: drugScreen
keywords: NF2 Meningioma drug screen proteasome inhibitor cell viability CRISPR arachnoidal cells Ben-Men-1 MN597 AC-CRISPR
accessType: Public Access
contributor: Roberta Beauchamp Lei Xu Massachusetts General Hospital
description: Drug screen data evaluating the efficacy of proteasome-targeting drugs on NF2-deficient human meningioma cell lines (Ben-Men-1, MN597) and CRISPR-Cas9 edited arachnoidal cells (AC-CRISPR). Includes cell viability assay results.
diseaseFocus: NF2-related schwannomatosis
alternateName: NF2 Meningioma Drug Screen
manifestation: Meningioma
dataUseModifiers: General Research Use
measurementTechnique: cell viability assay
includedInDataCatalog: https://www.synapse.org/DataCatalog:0
Drop files to upload
Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this
AJAX application crawl link
Proteasome-targeting drugs tested on NF2-deficient meningioma models
page is loading…